Health Care & Life Sciences » Pharmaceuticals | Pharmally International Holding Co. Ltd.

Pharmally International Holding Co. Ltd.

Pharmally International Holding Co. Ltd.
Stock Exchange Taiwan Stock Exchange
EPS
TWD14.61
Market Cap
TWD18.1 T
Shares Outstanding
78 M
Public Float
45.19 M

Profile

Address
18th Floor
Taipei TP 11012
Taiwan
Employees -
Website http://www.pharmally.com
Updated 07/08/2019
Pharmally International Holding Co., Ltd. engages in the manufacture and sale of infusion and active pharmaceutical ingredient (API) products. It focuses on basic infusion, infusion therapy, and API. Its products include glucose, sodium chloride, glucose & sodium chloride, compound sodium chloride, lactated ringer's, dextran 40 glucose, dextran 20 glucose, ambroxol hydrochloride & glucose, levofloxacin lactate & sodium chloride injections, nikethamide, dextran powder, and levofloxacin lactate powder.

Financials

View All

Wen-Lai Huang
Chairman & General Manager
Tzu Yan Huang
Director